首页> 外文期刊>Journal of Medical Genetics >Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
【24h】

Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.

机译:分析大肠癌家族中的体细胞分子变化,临床病理特征,家族史和种系突变:有效诊断HNPCC以及存在非HNPCC家族不同群体的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To analyse somatic molecular changes, clinicopathological features, family history, and germline mutations in families with colorectal cancer (CRC). METHODS: Molecular changes (K-ras and beta-catenin mutations, chromosome 18q allele loss (LOH), APC LOH, microsatellite instability (MSI), and expression of beta-catenin and p53) were examined in four series of CRC patients with proven or probable hereditary disease: hereditary non-polyposis colon cancer (HNPCC); MYH associated polyposis (MAP); multiple (>5) colorectal adenomas without familial adenomatous polyposis (FAP); and other families/cases referred to family cancer clinics (FCC series). HNPCC was diagnosed using a combination of germline mutation screening and tumour studies. A series of unselected CRC patients was also studied. RESULTS: There was overlap between genetic pathways followed by each type of CRC, but significant differences included: increased frequency of K-ras mutation and reduced frequency of APC LOH in cancers from MAP, but not from multiple adenoma patients; reduced frequency of LOH in HNPCC CRCs; and increased MSI in CRCs from HNPCC, but not from FCC or multiple adenoma patients. HNPCC was apparently detected efficiently by combined germline and somatic analysis. Cancers from the FCC, unselected, and multiple adenoma series shared similar molecular characteristics. In the FCC and multiple adenoma series, hierarchical cluster analysis using the molecular features of the cancers consistently identified two distinct groups, distinguished by presence or absence of K-ras mutation. CONCLUSIONS: While K-ras mutation status is known to differentiate hereditary bowel cancer syndromes such as MAP and FAP, it may also distinguish groups of non-HNPCC, FCC patients whose disease has different, as yet unknown, genetic origins.
机译:目的:分析结直肠癌(CRC)家庭的体细胞分子变化,临床病理特征,家族史和种系突变。方法:检查了四组经证实的CRC患者的分子变化(K-ras和β-catenin突变,染色体18q等位基因丢失(LOH),APC LOH,微卫星不稳定性(MSI)以及β-catenin和p53的表达)。或可能的遗传性疾病:遗传性非息肉性结肠癌(HNPCC); MYH相关性息肉病(MAP);无家族性腺瘤性息肉病(FAP)的多发(> 5)大肠腺瘤;以及其他家庭/诊所的家庭癌症病例(FCC系列)。使用种系突变筛选和肿瘤研究相结合的方法诊断出HNPCC。还研究了一系列未选出的CRC患者。结果:每种类型的CRC的遗传途径之间存在重叠,但显着差异包括:MAP癌症中K-ras突变频率增加,APC LOH频率降低,但多发腺瘤患者则无此差异。 HNPCC CRC中LOH频率降低; HNPCC引起的CRC中MSI升高,但FCC或多发性腺瘤患者则没有。结合种系和体细胞分析显然可以有效地检测到HNPCC。来自FCC,未选择和多个腺瘤系列的癌症具有相似的分子特征。在FCC和多个腺瘤系列中,利用癌症分子特征进行的层次聚类分析一致地确定了两个不同的组,以存在或不存在K-ras突变为特征。结论:虽然已知K-ras突变状态可以区分遗传性肠癌综合症,例如MAP和FAP,但它也可以区分疾病起源不同但遗传来源未知的非HNPCC,FCC患者组。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号